Evaluation of the efficacy of a traditional product on fatty liver

Evaluation of the efficacy of traditional medicine based on Coriandrum sativum in comparison with placebo on the ultrasound grade and serum level of liver enzymes in patients with non-alcoholic fatty liver

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20131214015790N3

Enrollment

Registered

2020-12-06

Start date

2020-12-05

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-alcoholic fatty liver. Nonalcoholic steatohepatitis (NASH)

Interventions

Intervention 1: Intervention group: The intervention group is given four tablets daily (two in the morning on an empty stomach and two at night at bedtime) of traditional medicine based on coriander f

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Confirmation of diagnosis of non-alcoholic fatty liver based on ultrasound (grades 1 to 3) Age 18 to 70 years Written and informed consent of the patient

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding Fatty liver secondary to alcohol consumption Smoking Taking hypoglycemic, hypolipidemic and anti-inflammatory drugs (any drug that affects liver function) Other diseases such as viral hepatitis, coronary artery disease, kidney, lung and thyroid diseases

Design outcomes

Primary

Measure	Time frame
Fatty liver ultrasound grade. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Ultrasound in the same radiology center.;Serum AST level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.;Serum ALT level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.;Serum Alk-P level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.	—

Measure

Time frame

Fatty liver ultrasound grade. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Ultrasound in the same radiology center.;Serum AST level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.;Serum ALT level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.;Serum Alk-P level. Timepoint: Beginning and end of the study (end of the second month). Method of measurement: Beckman DU spectrophotometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehrzad Mehrbani

Kerman University of Medical Sciences

mzmehrbani@yahoo.com+98 34 3211 0360

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026